Literature DB >> 19101151

Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold.

M Kyle Hadden1, Stephanie A Hill, Jason Davenport, Robert L Matts, Brian S J Blagg.   

Abstract

High-throughput screening of a library of diverse molecules has identified the 1,4-naphthoquinone scaffold as a new class of Hsp90 inhibitors. The synthesis and evaluation of a rationally-designed series of analogues containing the naphthoquinone core scaffold has provided key structure-activity relationships for these compounds. The most active inhibitors exhibited potent in vitro activity with low micromolar IC(50) values in anti-proliferation and Her2 degradation assays. In addition, 3g, 12, and 13a induced the degradation of oncogenic Hsp90 client proteins, a hallmark of Hsp90 inhibition. The identification of these naphthoquinones as Hsp90 inhibitors provides a new scaffold upon which improved Hsp90 inhibitors can be developed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101151      PMCID: PMC2669315          DOI: 10.1016/j.bmc.2008.11.064

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  19 in total

1.  Structure-based discovery of a new class of Hsp90 inhibitors.

Authors:  Xavier Barril; Paul Brough; Martin Drysdale; Roderick E Hubbard; Andrew Massey; Allan Surgenor; Lisa Wright
Journal:  Bioorg Med Chem Lett       Date:  2005-10-03       Impact factor: 2.823

2.  The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.

Authors:  Kwai-Ming J Cheung; Thomas P Matthews; Karen James; Martin G Rowlands; Katherine J Boxall; Swee Y Sharp; Alison Maloney; S Mark Roe; Chrisostomos Prodromou; Laurence H Pearl; G Wynne Aherne; Edward McDonald; Paul Workman
Journal:  Bioorg Med Chem Lett       Date:  2005-07-15       Impact factor: 2.823

3.  Derrubone, an inhibitor of the Hsp90 protein folding machinery.

Authors:  M Kyle Hadden; Lakshmi Galam; Jason E Gestwicki; Robert L Matts; Brian S J Blagg
Journal:  J Nat Prod       Date:  2007-11-17       Impact factor: 4.050

4.  High-throughput screening for Hsp90 ATPase inhibitors.

Authors:  Christopher Avila; M Kyle Hadden; Zeqiang Ma; Boris A Kornilayev; Qi-Zhuang Ye; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2006-03-10       Impact factor: 2.823

5.  Synthesis and evaluation of derrubone and select analogues.

Authors:  Jedidiah M Hastings; M Kyle Hadden; Brian S J Blagg
Journal:  J Org Chem       Date:  2007-12-22       Impact factor: 4.354

6.  Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice.

Authors:  Hai-Ying Shen; Jin-Cai He; Yumei Wang; Qing-Yuan Huang; Jiang-Fan Chen
Journal:  J Biol Chem       Date:  2005-10-06       Impact factor: 5.157

7.  Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization.

Authors:  Rudi K Allan; Danny Mok; Bryan K Ward; Thomas Ratajczak
Journal:  J Biol Chem       Date:  2006-01-17       Impact factor: 5.157

Review 8.  Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation.

Authors:  Brian S J Blagg; Timothy D Kerr
Journal:  Med Res Rev       Date:  2006-05       Impact factor: 12.944

Review 9.  Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.

Authors:  M Kyle Hadden; Donna J Lubbers; Brian S J Blagg
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

10.  Development of a fluorescence polarization assay for the molecular chaperone Hsp90.

Authors:  Joungnam Kim; Sara Felts; Laura Llauger; Huazhong He; Henri Huezo; Neal Rosen; Gabriela Chiosis
Journal:  J Biomol Screen       Date:  2004-08
View more
  18 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  A Scaffold Merging Approach to Hsp90 C-terminal Inhibition: Synthesis and Evaluation of a Chimeric Library.

Authors:  Rachel E Davis; Zheng Zhang; Brian S J Blagg
Journal:  Medchemcomm       Date:  2017-01-17       Impact factor: 3.597

3.  Design, synthesis, and biological evaluation of ring-constrained novobiocin analogues as hsp90 C-terminal inhibitors.

Authors:  Gaurav Garg; Huiping Zhao; Brian S J Blagg
Journal:  ACS Med Chem Lett       Date:  2014-12-12       Impact factor: 4.345

4.  Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.

Authors:  Yakini Brandy; Innocent Ononiwu; Dolapo Adedeji; Vonetta Williams; Claudia Mouamba; Yasmine Kanaan; Robert L Copeland; Dwayne A Wright; Ray J Butcher; Samuel R Denmeade; Oladapo Bakare
Journal:  Invest New Drugs       Date:  2011-01-18       Impact factor: 3.850

5.  Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.

Authors:  M Kyle Hadden; Brian S J Blagg
Journal:  J Org Chem       Date:  2009-07-03       Impact factor: 4.354

6.  Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.

Authors:  Jung A Woo; Tian Liu; Xingyu Zhao; Courtney Trotter; Ksenia Yrigoin; Sara Cazzaro; Emilio De Narvaez; Hirah Khan; Richard Witas; Anusha Bukhari; Kamal Makati; Xinming Wang; Chad Dickey; David E Kang
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

7.  High-throughput screen of natural product libraries for hsp90 inhibitors.

Authors:  Jason Davenport; Maurie Balch; Lakshmi Galam; Antwan Girgis; Jessica Hall; Brian S J Blagg; Robert L Matts
Journal:  Biology (Basel)       Date:  2014-02-10

8.  Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways.

Authors:  Ya-Jun Zhang; Zhi-Gang Xu; Shi-Qiang Li; Liu-Jun He; Yan Tang; Zhong-Zhu Chen; Dong-Lin Yang
Journal:  Cancer Cell Int       Date:  2018-06-28       Impact factor: 5.722

9.  Synthesis and characterization of novel unsymmetrical and symmetrical 3-halo- or 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone derivatives.

Authors:  Yakini Brandy; Nailah Brandy; Emmanuel Akinboye; Malik Lewis; Claudia Mouamba; Seshat Mack; Ray J Butcher; Alan J Anderson; Oladapo Bakare
Journal:  Molecules       Date:  2013-02-04       Impact factor: 4.411

Review 10.  Biosynthesis and molecular actions of specialized 1,4-naphthoquinone natural products produced by horticultural plants.

Authors:  Joshua R Widhalm; David Rhodes
Journal:  Hortic Res       Date:  2016-09-21       Impact factor: 6.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.